The Benefits of COVID-19 Vaccination for Pregnant Patients Hospitalized with Respiratory Symptoms: A Retrospective Cohort Study in South Brazil
- PMID: 39772105
- PMCID: PMC11680175
- DOI: 10.3390/vaccines12121445
The Benefits of COVID-19 Vaccination for Pregnant Patients Hospitalized with Respiratory Symptoms: A Retrospective Cohort Study in South Brazil
Abstract
Objectives: SARS-CoV-2 infection is a known risk factor for adverse health outcomes in pregnancy, affecting both maternal and neonatal health. Mounting evidence suggests that even a single dose of an approved COVID-19 vaccine protects against severe SARS-CoV-2 infection and is safe for both pregnant persons and neonates. Southern Brazil was heavily affected by the COVID-19 pandemic, and the protective effects of the vaccine on maternal and neonatal health are not well described. This study aims to examine the protective effects of maternal COVID-19 vaccination on both maternal and neonatal outcomes following SARS-CoV-2 infection during pregnancy.
Methods: This is a retrospective cohort study that leveraged medical data from a tertiary center in South Brazil to compare maternal and infant outcomes between hospitalized pregnant persons with and without SARS-CoV-2 infection between 1 March 2020, and 1 March 2023.
Results: In total, 524 patients were enrolled, including 275 pregnant patients with confirmed SARS-CoV-2 infection and 249 without infection. SARS-CoV-2 infection was associated with maternal ventilator support (adjusted Risk Ratio [aRR] = 1.48, 95% Confidence Interval [95% CI]: 1.08-2.03), while receipt of at least one dose of COVID-19 vaccine was associated with protection against maternal sepsis (aRR = 0.14, 95% CI: 0.03-0.56), intensive care unit (ICU) admission (aRR = 0.27, 95% CI: 0.10-0.68), need for ventilator support (aRR = 0.60, 95% CI: 0.43-0.84), infant admission to the neonatal intensive care unit (NICU) (aRR = 0.62, 95% CI: 0.47-0.82), and neonatal respiratory distress (aRR = 0.60, 95% CI: 0.43-0.83).
Conclusions: These findings further underscore the importance of maternal vaccination against COVID-19 during pregnancy. Even one dose of vaccine was protective against a variety of maternal and neonatal outcomes. Prenatal care should encourage COVID-19 vaccination in pregnancy.
Keywords: COVID-19; SARS-CoV-2; pregnancy outcomes; vaccination.
Conflict of interest statement
All authors deny any conflicts of interest.
Figures
Similar articles
-
Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis.Rev Med Virol. 2023 May;33(3):e2434. doi: 10.1002/rmv.2434. Epub 2023 Mar 10. Rev Med Virol. 2023. PMID: 36896895
-
Prenatal interventions for congenital diaphragmatic hernia for improving outcomes.Cochrane Database Syst Rev. 2015 Nov 27;2015(11):CD008925. doi: 10.1002/14651858.CD008925.pub2. Cochrane Database Syst Rev. 2015. PMID: 26611822 Free PMC article.
-
Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes.Cochrane Database Syst Rev. 2015 Jun 9;2015(6):CD009982. doi: 10.1002/14651858.CD009982.pub2. Cochrane Database Syst Rev. 2015. PMID: 26059051 Free PMC article.
-
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study.NIHR Open Res. 2024 Nov 5;4:1. doi: 10.3310/nihropenres.13517.3. eCollection 2024. NIHR Open Res. 2024. PMID: 39931702 Free PMC article.
-
Pushing/bearing down methods for the second stage of labour.Cochrane Database Syst Rev. 2015 Oct 9;(10):CD009124. doi: 10.1002/14651858.CD009124.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Mar 26;3:CD009124. doi: 10.1002/14651858.CD009124.pub3. PMID: 26451755 Updated.
References
-
- da Silva C.G., Daboin B.E.G., de Mello Monteiro C.B. Analysis of incidence, mortality and lethality by COVID-19 in the States of Pará and Rio Grande do Sul, Brazil: Epidemiological aspects of evolution 2020–2022. J. Hum. Growth Dev. 2023;33:431–443. doi: 10.36311/jhgd.v33.15287. - DOI
-
- BOLETIM EPIDEMIOLÓGICO ESPECIAL—Secretaria de Vigilância em Saúde—Ministério da Saúde. [(accessed on 15 May 2024)]; Available online: https://www.gov.br.
-
- Carvalho I.C., Mascarenhas M.D., Rodrigues M.T., Andrade J.X., Nascimento F.F., Penha J.C. Impact of the COVID-19 pandemic on the maternal mortality rate in Brazil: Trend and spatial distribution. Rev. Gaúcha Enferm. 2024;45:e20230299. doi: 10.1590/1983-1447.2024.20230299.pt. - DOI - PubMed
-
- Atlas do Desenvolvimento Humano no Brasil. AtlasBR. [(accessed on 5 December 2024)]. Available online: http://www.atlasbrasil.org.br/ranking.
-
- Di Mascio D., Khalil A., Saccone G., Rizzo G., Buca D., Liberati M., Vecchiet J., Nappi L., Scambia G., Berghella V., et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2020;2:100107. doi: 10.1016/j.ajogmf.2020.100107. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous